Nathaniel Jonathan Berky: New Protein-Binding Insight May Transform Personalised IVF
Nathaniel Jonathan Berky, Venture Architect, shared a post on LinkedIn:
“This is an important advance for reproductive health.
Understanding fertilisation at this molecular-mechanical level brings us closer to a truly personalised IVF journey in which fit-for-purpose treatment (rather than ‘unexplained’) can be identified within a failed cycle.
If this protein-binding mechanism can be verified in the clinic, it could shorten the trial and error aspect of treatment, improve IVF success rates, and change how we screen patients to prepare them for a cycle.
Switzerland is well placed for this next stage: we have good research (Basel, ETH-Department of Biosystems Science and Engineering (D-BSSE)), the biotech translation capacity, and a patient group who would expect evidence-based care than just fertility standard protocols.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 30, 2026, 18:45AI in Ultrasound Follicular Monitoring Moves Toward Clinical Decision Support – RBMO
-
Apr 30, 2026, 11:42ASRM Encourages Registration for Conference on Practice Growth and Innovation
-
Apr 30, 2026, 11:26ESHRE and ALPHA Launch Global Survey to Update ART Laboratory KPIs
-
Apr 30, 2026, 11:10Susanne Johnson: Advanced Gynaecology Ultrasound Course Day 2
-
Apr 30, 2026, 11:02Platelets Reduce Oxidative Stress Damage in Human Endometrial Stromal Cells in Vitro – RBMO
-
Apr 30, 2026, 10:57GREEG Day 2026: Elevate Your Ultrasound Expertise – GREEG
-
Apr 30, 2026, 10:49Up to Two-Thirds of Elite Female Athletes Experience Irregular Periods – Fertility Plus
-
Apr 30, 2026, 10:47Applications for the ESHRE5 Young Ambassadors 2026 are Still OPEN, But Not for Long! – ESHRE
-
Apr 30, 2026, 10:42The Link Between Lifestyle and Anti-Müllerian Hormone – RBMO